Publications
Specialty
Search
Vascular Disease Management
08/14/2024
Caroline E. Fife, MD
APP Institute Dermatology
08/14/2024
Explore the basic mechanisms of itch with Dr Brian Kim.
Vascular Disease Management
08/14/2024
On Wednesday morning, Chris Fox, senior vice president of external affairs at the American Diabetes Association (ADA), presented the latest information on the ADA’s Amputation Prevention Alliance (APA).
Vascular Disease Management
08/14/2024
At Wednesday’s session on CLI in 2024, Laiq Raja, MD, FACC, FSCAI, from El Paso Cardiology Associates in El Paso, Texas, presented on the effective management of complex critical limb ischemia (CLI) patients with wounds in an outpatient program.
Vascular Disease Management
08/14/2024
Yolanda Bryce, MD, RPVI
Neurology, Psych Congress Network
08/14/2024
Collaborative dementia care management (CDCM) was associated with improved patient and caregiver outcomes over 3 years after the initial care period, according to results from a randomized controlled trial published in JAMA Network Open. U
Oncology
08/14/2024
The US Food and Drug Administration approved axatilimab for the treatment of adult and pediatric patients with chronic graft-versus-host disease following a failure of at least 2 prior lines of systemic therapy.
EMSWorld, Emergency & Mobile Medicine
08/14/2024
How an Illinois service took a simple mission statement to embark on a 10-year journey toward excellence in patient outcomes
Oncology
08/14/2024
Triple-negative myelofibrosis was found to be continually associated with decreased survival in addition to enhanced aggressive behavior with higher rates of leukemic transformation as well as a shorter duration of response to ruxolitinib, determined a recent study.
Wound Care
08/14/2024
A 375-patient RCT initiated by BioLab Sciences will evaluate the efficacy of human amniotic membrane(s) on difficult-to-heal partial- or full-thickness VLUs in elderly patients with primary outcome of time and frequency of wound closure up to 12 weeks. Estimated completion is Aug 2026. clinicaltrials.gov
Wound Care
08/14/2024
InfuSystem announced a US distribution agreement with Smith+Nephew for its NPWT system, Renasys Edge, in home-based care. SmartTRAK notes that Renasys Edge was launched in the US in April 2024. InfuSystem will be a secondary distributor, and SNN will continue selling directly.
Wound Care
08/14/2024
This meta-analysis showed that late dressing changes significantly increase the risks of wound infection, and changes at 48 hours minimize these risks. There was no advantage demonstrated for earlier dressing changes. Ann R Coll Surg Engl
Wound Care
08/14/2024
Integra/ACell received 510(k) clearance for MicroMatrix, a porcine-derived UBM particulate, for an extended shelf-life from 2 to 3 years. It also received 510(k) clearance for Cytal Wound and Burn Matrix, a porcine-derived ECM, for an extended shelf-life from 2 to 3 years.
Wound Care
08/14/2024
This study evaluated the effect of silver dressings in the management of chronic wounds. The results revealed that they could enhance the healing rate, shorten the healing time, and reduce the wound infection rate. They had no significant effect on the reduction of wound area. IWJ
Wound Care
08/14/2024
MediWound announced the results of the 239-patient NEXT Protocol. The open-label, single-arm treatment study took place across 29 burn centers. Results showed over 95% of patients achieved complete debridement, with the time to complete eschar removal being less than one day.
Wound Care
08/14/2024
A study involving 22 patients with laparotomy for lower intestinal perforation who were closed with sutures and received incisional NPWT found that, when compared to a 65-patient historical control group, the study group had lower SSI (9.1% vs 52.3%, p<0.001). J Anus Rectum Colon
Oncology
08/14/2024
According to a phase 3 study, the addition of blinatumomab to consolidation chemotherapy for adult patients in measurable residual disease-negative remission from B-cell precursor acute lymphoblastic leukemia significantly improved overall survival.
Oncology
08/14/2024
Complete remission with partial hematological recovery as an efficacy end point was found to correlate with clinical benefits associated with clinically meaningful palliative effects for the treatment of patients with acute myeloid leukemia with non-myelosuppressive drugs.
Journal of Invasive Cardiology, CardioVascular
08/14/2024
The authors characterize radial artery patency after distal transradial access in patients with advanced chronic kidney disease in a retrospective, single-center, real-world study and compare outcomes with that of the largest published historical comparator of proximal transradial access in patients with advanced chronic kidney disease.
Oncology
08/14/2024
According to results from a phase 2 study, trastuzumab deruxtecan demonstrated promising activity among patients with HER2-expressing unresectable or recurrent biliary tract cancer.
Reimbursement Library From A to Z
Subscribe and never miss an article!
Today's Wound Clinic Newsletter
